Id,modularity_class,properties._n_name,properties.n_name
6002,27,"AMYOTROPHIC LATERAL SCLEROSIS, AMYOTROPHIC LATERAL SCLEROSIS, ORGOTEIN|ORGOTEIN FOR INJECTION, ALS|ALS1|HEL-S-44|HOMODIMER|HSOD1|IPOA|SOD|SOD1, MECASERMIN RINFABATE|IPLEX, MOTOR NEURON DISEASE, UNSPECIFIED, ESCLEROSIS LATERAL AMIOTRÓFICA, ESCLEROSIS LATERAL PRIMARIA JUVENIL, JUVENILE PRIMARY LATERAL SCLEROSIS|JPLS|JUVENILE PLS|PLSJ|PRIMARY LATERAL SCLEROSIS, JUVENILE, PLS, JUVENILE|PLSJ|PRIMARY LATERAL SCLEROSIS, JUVENILE, ALS2 GENE|AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE|KIAA1563|PRIMARY LATERAL SCLEROSIS, JUVENILE|SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING|ALSIN, LOU GEHRIG'S DISEASE|AMYOTROPHIC LATERAL SCLEROSIS, AMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL RECESSIVE, AMYOTROPHIC LATERAL SCLEROSIS|ALS|AMYOTROPHIC LATERAL SCLEROSIS WITH DEMENTIA|CHARCOT DISEASE|DEMENTIA WITH AMYOTROPHIC LATERAL SCLEROSIS|LOU GEHRIG DISEASE|MOTOR NEURON DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, ALS|AMYOTROPHIC LATERAL SCLEROSIS|LOU GEHRIG'S DISEASE, HUMAN CILIARY NEUROTROPHIC FACTOR, RECOMBINANT (E. COLI)|CILIARY NEUROTROPHIC FACTOR, RECOMBINANT HUMAN|CILIARY NEUROTROPHIC FACTOR, ACID LABILE SUBUNIT MEASUREMENT|ACID LABILE SUBUNIT|ALS|IGFALS|IGFALS MEASUREMENT|INSULIN LIKE GROWTH FACTOR BINDING PROTEIN ACID LABILE SUBUNIT, AMYOTROPHIC LATERAL SCLEROSIS|ALS|ALS1|AMYOTROPHIC LATERAL SCLEROSIS TYPE 1|CHARCOT DISEASE|LOU GEHRIG DISEASE|MND|MOTOR NEURONE DISEASE, nan, AMYOTROPHIC LATERAL SCLEROSIS|ALS|LOU GEHRIG DISEASE, ANTERIOR HORN CELL DISEASE|FAMILIAL MOTOR NEURON DISEASE|LATERAL SCLEROSES|LATERAL SCLEROSES, PRIMARY|LATERAL SCLEROSIS|LATERAL SCLEROSIS, PRIMARY|LOWER MOTOR NEURON DISEASE|MOTOR NEURON DISEASE, FAMILIAL|MOTOR NEURON DISEASE, LOWER|MOTOR NEURON DISEASE, SECONDARY|MOTOR NEURON DISEASE, UPPER|MOTOR NEURON DISEASES|MOTOR SYSTEM DISEASE|MOTOR SYSTEM DISEASES|NEURON DISEASE, MOTOR|NEURON DISEASES, MOTOR|PRIMARY LATERAL SCLEROSES|PRIMARY LATERAL SCLEROSIS|SCLEROSES, LATERAL|SCLEROSES, PRIMARY LATERAL|SCLEROSIS, LATERAL|SCLEROSIS, PRIMARY LATERAL|SECONDARY MOTOR NEURON DISEASE|UPPER MOTOR NEURON DISEASE|MOTOR NEURON DISEASE, ENFERMEDAD DE LAS MOTONEURONAS, GLIADIN|SUPEROXIDE DISMUTASE, GLIADIN|ETR019, ALS|ALS (AMYOTROPHIC LATERAL SCLEROSIS)|ALS - AMYOTROPHIC LATERAL SCLEROSIS|AMYOTROPHIC LATERAL SCLEROSIS|AMYOTROPHIC LATERAL SCLEROSIS (DISORDER)|AMYOTROPHIC LATERAL SCLEROSIS WITH DEMENTIA|AMYOTROPHIC LATERAL SCLEROSIS, GUAM FORM|AMYOTROPHIC LATERAL SCLEROSIS, PARKINSONISM/DEMENTIA COMPLEX OF GUAM|AMYOTROPHIC LATERAL SCLEROSIS-PARKINSONISM/DEMENTIA COMPLEX 1|AMYOTROPHIC SCLEROSIS|BULBAR MOTOR NEURON DISEASE|CHARCOT DISEASE|DEMENTIA WITH AMYOTROPHIC LATERAL SCLEROSIS|DISEASE, LOU-GEHRIGS|GEHRIG DISEASE|GEHRIG'S DISEASE|GEHRIGS DIS|GEHRIGS DISEASE|GUAM FORM OF AMYOTROPHIC LATERAL SCLEROSIS|LATERAL SCLEROSES, AMYOTROPHIC|LOU GEHRIG DIS|LOU GEHRIG DISEASE|LOU GEHRIG'S DISEASE|LOU GEHRIGS DIS|LOU GEHRIGS DISEASE|LOU-GEHRIGS DISEASE|MOTOR NEURON DIS AMYOTROPHIC LATERAL SCLEROSIS|MOTOR NEURON DISEASE, AMYOTROPHIC LATERAL SCLEROSIS|MOTOR NEURON DISEASE, BULBAR|SCLEROSIS, AMYOTROPHIC LATERAL, ALS1|AMYOTROPHIC LATERAL SCLEROSIS 1|AMYOTROPHIC LATERAL SCLEROSIS TYPE 1, MOTOR NEURON DISEASE, RILUZOLE|RILUZOLE ORAL SOLUBLE FILM (ROSF), ANTILYMPHOCYTE SERUM|ALG|ALS|ANTILYMPHOCYTE GLOBULIN|ANTILYMPHOCYTE SERUMS|SERUM, ANTILYMPHOCYTE|SERUMS, ANTILYMPHOCYTE, ALS - AMYOTROPHIC LATERAL SCLEROSIS|ALS AMYOTROPHIC LATERAL SCLEROSIS|AMYOTROPHIC LATERAL SCLEROSIS PARKINSONISM DEMENTIA COMPLEX 1|AMYOTROPHIC LATERAL SCLEROSIS WITH DEMENTIA|AMYOTROPHIC LATERAL SCLEROSIS, GUAM FORM|AMYOTROPHIC LATERAL SCLEROSIS, PARKINSONISM DEMENTIA COMPLEX OF GUAM|AMYOTROPHIC LATERAL SCLEROSIS, PARKINSONISM-DEMENTIA COMPLEX OF GUAM|AMYOTROPHIC LATERAL SCLEROSIS-PARKINSONISM-DEMENTIA COMPLEX 1|CHARCOT DISEASE|DEMENTIA WITH AMYOTROPHIC LATERAL SCLEROSIS|DISEASE, GUAM|DISEASE, LOU-GEHRIGS|GEHRIG DISEASE|GEHRIG'S DISEASE|GEHRIGS DISEASE|GUAM DISEASE|GUAM FORM OF AMYOTROPHIC LATERAL SCLEROSIS|LOU GEHRIG DISEASE|LOU GEHRIG'S DISEASE|LOU-GEHRIGS DISEASE|MOTOR NEURON DISEASE, AMYOTROPHIC LATERAL SCLEROSIS|SCLEROSIS, AMYOTROPHIC LATERAL|AMYOTROPHIC LATERAL SCLEROSIS, JUVENILE PRIMARY LATERAL SCLEROSIS, ACID-LABILE SUBUNIT|ACID-LABILE SUBUNIT DEFICIENCY|ALS|IGFALS|IGFBP, SOLUBLE|INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN, ACID-LABILE SUBUNIT, JUVENILE PRIMARY LATERAL SCLEROSIS|PRIMARY LATERAL SCLEROSIS, JUVENILE|PRIMARY LATERAL SCLEROSIS JUVENILE, MOTOR NEURON DISEASE, AT-1501|HUMANIZED ANTI-CD40LG IGG1, KAPPA MONOCLONAL ANTIBODY WITH HEAVY CHAIN C220S/C226S/C229S/P238S SUBSTITUTIONS TO ATTENUATE EFFECTOR FUNCTION|AT-1501 | TORALIZUMAB, AMYOTROPHIC LATERAL SCLEROSIS TYPE 2|ALS2, ALS|IGFALS, MOTOR NEURON DISEASE, AMYOTROPHIC LATERAL SCLEROSIS TYPE 6|ALS6, CEFTRIAXONE SODIUM|ROCEPHIN, ISOLEUCINE|BRANCHED CHAIN AMINO ACIDS, NICOTINAMIDE RIBOSIDE AND PTEROSTILBENE, ANTILYMPHOCYTE SERUM|ALG|ALS|ANTILYMPHOCYTE GLOBULIN, CU-ASTM|DIACETYL(N(4)-METHYLTHIOSEMICARBAZONATO) COPPER (II), OZANEZUMAB|ANTI-NOGO-A MONOCLONAL ANTIBODY, CANNABIDIOL |CANNABIDIOL AND DELTA-9-TETRAHYDROCANNABINOL, TELBERMIN|RECOMBINANT HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR,  PTEROSTILBENE|NICOTINAMIDE RIBOSIDE AND PTEROSTILBENE, OXALOACETIC ACID, L-THREONINE|THREOSTAT, GLATIRAMER ACETATE|COPAXONE, PROTIRELIN INJECTION, GM-603|OLIGOPEPTIDE CONTAINING 6 AMINO ACIDS (H-PHE-SER-ARG-TYR-ALA-ARG-OH), GABAPENTIN|NEURONTIN, MECASERMIN|MYOTROPHIN, DELTA-9-TETRAHYDROCANNABINOL|CANNABIDIOL AND DELTA-9-TETRAHYDROCANNABINOL, RILUZOLE|RILUTEK, RILUZOLE ORAL SUSPENSION|TEGLUTIK, OLESOXIME|4-CHOLEST-EN-3-ONE, OXIME, RILUZOLE ORALLY DISOLVING TABLET, PMX-205 ACETATE|HYDROCINNAMATE-[ORN-PRO-DCHA-TRP-ARG](CH3COO), MOTOR NEURON DISEASE, DL-3-N-BUTYLPHTHALIDE, CYCLOSPORIN A|MITOGARD, ALS|LOU GEHRIG'S DISEASE|MOTOR NEURON DISEASE, BULBAR|AMYOTROPHIC LATERAL SCLEROSIS, NOSCAPINE, DEXTROMETHORPHAN HYDROBROMIDE|DEXTROMETHORPHAN HYDROBROMIDE/QUINIDINE SULFATE|NUEDEXTA, AMYOTROPHIC LATERAL SCLEROSIS|ALS|AMYOTROPHIC LATERAL SCLEROSIS-POLYGLUCOSAN BODIES|ARAN-DUCHENNE MUSCULAR ATROPHY|GEHRIG'S DISEASE|LOU GEHRIG'S DISEASE|MOTOR SYSTEM DISEASE (FOCAL AND SLOW), 4-CHOLEST-EN-3-ONE, OXIME, LEVOSIMENDAN, SARSASAPOGENIN, CILIARY NEUROTROPHIC FACTOR, nan, TALAMPANEL, ALS1|AMYOTROPHIC LATERAL SCLEROSIS 1|AMYOTROPHIC LATERAL SCLEROSIS TYPE 1|AMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT|AMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT AMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL RECESSIVE, INCLUDED|AMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL RECESSIVE|AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL|AMYOTROPHIC LATERAL SCLEROSIS 1; ALS1|AMYOTROPHIC LATERAL SCLEROSIS, AUTOSOMAL DOMINANT|AMYOTROPHIC LATERAL SCLEROSIS, FAMILIAL|AMYOTROPHIC LATERAL SCLEROSIS, SPORADIC|AMYOTROPHIC LATERAL SCLEROSIS, SPORADIC, INCLUDED, LSP-GR3|2'-O-METHYL PHOSPHOROTHIOATE 5'-GCUAGGUUUACGGGACCUCU-3', JUVENILE PRIMARY LATERAL SCLEROSIS|JPLS|PLS JUVENILE|PRIMARY LATERAL SCLEROSIS, JUVENILE, ARIMOCLOMOL, BIS-CHOLINE TETRATHIOMOLYBDATE, SODIUM CHLORITE, TIRASEMTIV, LEUCINE|BRANCHED CHAIN AMINO ACIDS, SMILAGENIN|COGANE, GLIADIN|SUPEROXIDE DISMUTASE, GLIADIN|ETR019, VALINE|BRANCHED CHAIN AMINO ACIDS, EPI-589|(R)-2-HYDROXY-2-METHYL-4-(2,4,5-TRIMETHYL-3,6-DIOXOCYCLOHEXA-1,4-DIEN-1-YL) BUTANAMIDE, ALS1|AMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT|AMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL RECESSIVE|AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL|AMYOTROPHIC LATERAL SCLEROSIS, SPORADIC|FALS|AMYOTROPHIC LATERAL SCLEROSIS 1, AMYOTROPHIC LATERAL SCLEROSIS, ACTH|REPOSITORY CORTICORTROPIN INJECTION|H.P. ACTHAR GEL, QUINIDINE SULFATE|DEXTROMETHORPHAN HYDROBROMIDE/QUINIDINE SULFATE|NUEDEXTA, IBUDILAST, CREATINE|CREAPURE,  SODIUM PHENYLBUTYRATE|COMBINATION OF SODIUM PHENYLBUTYRATE AND TAUROURSODEOXYCHOLIC ACID DIHYDRATE, ORGOTEIN FOR INJECTION, FILGRASTIM, LACTOBACILLUS PLANTARUM, AMYOTROPHIC LATERAL SCLEROSIS|ALS|ALS - AMYOTROPHIC LATERAL SCLEROSIS|ALS AMYOTROPHIC LATERAL SCLEROSIS|AMYTROPHIC LATERAL SCLEROSIS|BULBAR MOTOR NEURON DISEASE|CHARCOT DISEASE|DISEASE, LOU-GEHRIGS|GEHRIG DISEASE|GEHRIG'S DISEASE|GEHRIGS DISEASE|LOU GEHRIG DISEASE|LOU GEHRIG'S DISEASE|LOU-GEHRIGS DISEASE|MOTOR NEURON DISEASE, AMYOTROPHIC LATERAL SCLEROSIS|SCLEROSIS, AMYOTROPHIC LATERAL, EDARAVONE, EDARAVONE, DEXPRAMIPEXOLE, L-2-OXOTHIAZOLIDINE-4-CARBOXYLIC ACID|PROCYSTEINE, MASITINIB MESYLATE, AEOL-10150|[5,10,15,20-TETRAKIS(1,3-DIETHYLIMIDAZOLIUM-2-YL)PORPHYRINATO] MANGANESE(III)PENTACHLORIDE, HER-902 |RECOMBINANT HUMAN CEREBRAL DOPAMINE NEUROTROPHIC FACTOR,  TAUROURSODEOXYCHOLIC ACID DIHYDRATE|COMBINATION OF SODIUM PHENYLBUTYRATE AND TAUROURSODEOXYCHOLIC ACID DIHYDRATE, NI-204|RECOMBINANT HUMAN ANTIBODY DIRECTED AGAINST HUMAN MISFOLDED SUPEROXIDE DISMUTASE 1, CILIARY NEUROTROPHIC FACTOR, RECOMBINANT HUMAN, NEUROTROPHIN-1, RECOMBINANT METHIONYL BRAIN-DERIVED NEUROTROPHIC FACTOR, PHOSPHOROTHIOATE OLIGONUCLEOTIDE, AUTOLOGOUS OLFACTORY NEURAL PROGENITORS|RHINOCYTES, EPI-589|(R)-2-HYDROXY-2-METHYL-4-(2,4,5-TRIMETHYL-3,6-DIOXOCYCLOHEXA-1,4-DIEN-1-YL) BUTANAMIDE, CAPRINE HYPERIMMUNE SERUM AGAINST HIV LYSATE, NDX-PEPTIDES, EX-VIVO EXPANDED AUTOLOGOUS BONE MARROW-DERIVED MESENCHYMAL STEM CELLS, ALS|CHARCOT DISEASE|LOU GEHRIG DISEASE|LOU GEHRIG'S DISEASE|MOTOR NEURON DISEASE, BULBAR|AMYOTROPHIC LATERAL SCLEROSIS, HUMAN SPINAL CORD DERIVED NEURAL STEM CELLS, AEOL-10150|[5,10,15,20-TETRAKIS(1,3-DIETHYLIMIDAZOLIUM-2-YL)PORPHYRINATO] MANGANESE(III)PENTACHLORIDE, MESENCHYMAL STROMAL CELLS SECRETING NEUROTROPHIC FACTORS|NUROWN, HEAT SHOCK PROTEIN 70, HUMAN UMBILICAL TISSUE DERIVED CELLS (HUTC), ALS|ALS (AMYOTROPHIC LATERAL SCLEROSIS)|AMYOTROPHIC LATERAL SCLEROSIS|AMYOTROPHIC LATERAL SCLEROSIS (DISORDER)|AMYOTROPHIC LATERAL SCLEROSIS, GUAM FORM|AMYOTROPHIC SCLEROSIS|DEMENTIA WITH AMYOTROPHIC LATERAL SCLEROSIS|DISEASE, LOU-GEHRIGS|GEHRIG DISEASE|GEHRIGS DIS|GEHRIGS DISEASE|GUAM FORM OF AMYOTROPHIC LATERAL SCLEROSIS|LATERAL SCLEROSES, AMYOTROPHIC|LOU GEHRIG DIS|LOU GEHRIG DISEASE|LOU GEHRIG'S DISEASE|LOU GEHRIGS DIS|MOTOR NEURON DIS AMYOTROPHIC LATERAL SCLEROSIS|MOTOR NEURON DISEASE, AMYOTROPHIC LATERAL SCLEROSIS|MOTOR NEURON DISEASE, BULBAR, HUMAN GLIAL RESTRICTED PROGENITOR CELLS AND THEIR PROGENY|Q-CELLS, SOD1 WT ALLELE|ALS|ALS1|IPOA|SOD|SUPEROXIDE DISMUTASE 1, SOLUBLE (AMYOTROPHIC LATERAL SCLEROSIS 1 (ADULT)) WT ALLELE, ALLOGENEIC MOTOR NEURON PROGENITOR CELLS DERIVED FROM HUMAN EMBRYONIC STEM CELLS|MOTORGRAFT (TM), DNA PLASMID VECTOR (PCK-HGFX7) EXPRESSING HUMAN HEPATOCYTE GROWTH FACTOR, JUVENILE PRIMARY LATERAL SCLEROSIS|JPLS|JUVENILE PLS|PLS JUVENILE|PLS, JUVENILE|PLSJ|PRIMARY LATERAL SCLEROSIS JUVENILE|PRIMARY LATERAL SCLEROSIS, JUVENILE, AUTOLOGOUS ADIPOSE DERIVED MESENCHYMAL STROMAL CELLS, MONONUCLEAR ENRICHED FRACTION OF HUMAN UMBILICAL CORD BLOOD|U-CORD-CELL(R), ANTISENSE OLIGONUCLEOTIDE INHIBITOR OF THE EXPRESSION OF SUPEROXIDE DISMUTASE 1 GENE, AMYOTROPHIC LATERAL SCLEROSIS TYPE 11|ALS11|AMYOTROPHIC LATERAL SCLEROSIS 11, ELECTROKINETICALLY ALTERED SALINE SOLUTION WITH AN ELEVATED DISSOLVED OXYGEN CONCENTRATION, AMYOTROPHIC LATERAL SCLEROSIS TYPE 10|ALS10|AMYOTROPHIC LATERAL SCLEROSIS 10, HUMANIZED ANTI-CD40LG IGG1, KAPPA MONOCLONAL ANTIBODY WITH HEAVY CHAIN C220S/C226S/C229S/P238S SUBSTITUTIONS TO ATTENUATE EFFECTOR FUNCTION, LENZUMESTROCEL, AMYOTROPHIC LATERAL SCLEROSIS TYPE 9|ALS9|AMYOTROPHIC LATERAL SCLEROSIS 9, MOTOR NEURON DISEASE|ANTERIOR HORN CELL DISEASE|DEGENERATIVE MOTOR SYSTEM DISEASE|DISEASE OF MOTOR NEURON|DISEASE OR DISORDER OF MOTOR NEURON|DISORDER OF MOTOR NEURON|MND - MOTOR NEURONE DISEASE|MOTOR NEURON DISEASE OR DISORDER|MOTOR NEURON DISEASES|MOTOR NEURONE DISEASE|MOTOR SYSTEM DISEASE|MOTOR SYSTEM DISEASES|NEURON DISEASE, MOTOR|NEURON DISEASES, MOTOR, S-[+]-APOMORPHINE, CLENBUTEROL|SPIROPENT, AMYOTROPHIC LATERAL SCLEROSIS TYPE 8|ALS8|AMYOTROPHIC LATERAL SCLEROSIS 8, AMYOTROPHIC LATERAL SCLEROSIS TYPE 1|ALS1|AMYOTROPHIC LATERAL SCLEROSIS 1|AMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT|AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL|AMYOTROPHIC LATERAL SCLEROSIS, AUTOSOMAL DOMINANT|FALS|SOD1-RELATED AMYOTROPHIC LATERAL SCLEROSIS, AMYOTROPHIC LATERAL SCLEROSIS, SPORADIC, AMYOTROPHIC LATERAL SCLEROSIS TYPE 4|ALS4|AMYOTROPHIC LATERAL SCLEROSIS 4, AMYOTROPHIC LATERAL SCLEROSIS TYPE 5|ALS5|AMYOTROPHIC LATERAL SCLEROSIS 5, AMYOTROPHIC LATERAL SCLEROSIS|ALS|LOU GEHRIG DISEASE, AMYOTROPHIC LATERAL SCLEROSIS 1, AMYOTROPHIC LATERAL SCLEROSIS, PRIMARY LATERAL SCLEROSIS, JUVENILE, JPLS|JUVENILE PLS|PLS JUVENILE|PLS, JUVENILE|PRIMARY LATERAL SCLEROSIS, JUVENILE|PRIMARY LATERAL SCLEROSIS, JUVENILE; PLSJ|JUVENILE PRIMARY LATERAL SCLEROSIS, JPLS|JUVENILE PLS|JUVENILE PRIMARY LATERAL SCLEROSIS|PLS JUVENILE|PLS, JUVENILE|PRIMARY LATERAL SCLEROSIS, JUVENILE|PRIMARY LATERAL SCLEROSIS, JUVENILE; PLSJ","AMYOTROPHIC LATERAL SCLEROSIS, AMYOTROPHIC LATERAL SCLEROSIS, ['ORGOTEIN', 'ORGOTEIN FOR INJECTION'], ['ALS', 'ALS1', 'HEL-S-44', 'HOMODIMER', 'HSOD1', 'IPOA', 'SOD', 'SOD1'], ['MECASERMIN RINFABATE', 'IPLEX'], MOTOR NEURON DISEASE, UNSPECIFIED, ESCLEROSIS LATERAL AMIOTRÓFICA, ESCLEROSIS LATERAL PRIMARIA JUVENIL, ['JUVENILE PRIMARY LATERAL SCLEROSIS', 'JPLS', 'JUVENILE PLS', 'PLSJ', 'PRIMARY LATERAL SCLEROSIS, JUVENILE'], ['PLS, JUVENILE', 'PLSJ', 'PRIMARY LATERAL SCLEROSIS, JUVENILE'], ['ALS2 GENE', 'AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE', 'KIAA1563', 'PRIMARY LATERAL SCLEROSIS, JUVENILE', 'SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING', 'ALSIN'], [""LOU GEHRIG'S DISEASE"", 'AMYOTROPHIC LATERAL SCLEROSIS'], AMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL RECESSIVE, ['AMYOTROPHIC LATERAL SCLEROSIS', 'ALS', 'AMYOTROPHIC LATERAL SCLEROSIS WITH DEMENTIA', 'CHARCOT DISEASE', 'DEMENTIA WITH AMYOTROPHIC LATERAL SCLEROSIS', 'LOU GEHRIG DISEASE', 'MOTOR NEURON DISEASE, AMYOTROPHIC LATERAL SCLEROSIS'], ['ALS', 'AMYOTROPHIC LATERAL SCLEROSIS', ""LOU GEHRIG'S DISEASE""], ['HUMAN CILIARY NEUROTROPHIC FACTOR, RECOMBINANT (E. COLI)', 'CILIARY NEUROTROPHIC FACTOR, RECOMBINANT HUMAN', 'CILIARY NEUROTROPHIC FACTOR'], ['ACID LABILE SUBUNIT MEASUREMENT', 'ACID LABILE SUBUNIT', 'ALS', 'IGFALS', 'IGFALS MEASUREMENT', 'INSULIN LIKE GROWTH FACTOR BINDING PROTEIN ACID LABILE SUBUNIT'], ['AMYOTROPHIC LATERAL SCLEROSIS', 'ALS', 'ALS1', 'AMYOTROPHIC LATERAL SCLEROSIS TYPE 1', 'CHARCOT DISEASE', 'LOU GEHRIG DISEASE', 'MND', 'MOTOR NEURONE DISEASE'], nan, ['AMYOTROPHIC LATERAL SCLEROSIS', 'ALS', 'LOU GEHRIG DISEASE'], ['ANTERIOR HORN CELL DISEASE', 'FAMILIAL MOTOR NEURON DISEASE', 'LATERAL SCLEROSES', 'LATERAL SCLEROSES, PRIMARY', 'LATERAL SCLEROSIS', 'LATERAL SCLEROSIS, PRIMARY', 'LOWER MOTOR NEURON DISEASE', 'MOTOR NEURON DISEASE, FAMILIAL', 'MOTOR NEURON DISEASE, LOWER', 'MOTOR NEURON DISEASE, SECONDARY', 'MOTOR NEURON DISEASE, UPPER', 'MOTOR NEURON DISEASES', 'MOTOR SYSTEM DISEASE', 'MOTOR SYSTEM DISEASES', 'NEURON DISEASE, MOTOR', 'NEURON DISEASES, MOTOR', 'PRIMARY LATERAL SCLEROSES', 'PRIMARY LATERAL SCLEROSIS', 'SCLEROSES, LATERAL', 'SCLEROSES, PRIMARY LATERAL', 'SCLEROSIS, LATERAL', 'SCLEROSIS, PRIMARY LATERAL', 'SECONDARY MOTOR NEURON DISEASE', 'UPPER MOTOR NEURON DISEASE', 'MOTOR NEURON DISEASE'], ENFERMEDAD DE LAS MOTONEURONAS, ['GLIADIN', 'SUPEROXIDE DISMUTASE, GLIADIN', 'ETR019'], ['ALS', 'ALS (AMYOTROPHIC LATERAL SCLEROSIS)', 'ALS - AMYOTROPHIC LATERAL SCLEROSIS', 'AMYOTROPHIC LATERAL SCLEROSIS', 'AMYOTROPHIC LATERAL SCLEROSIS (DISORDER)', 'AMYOTROPHIC LATERAL SCLEROSIS WITH DEMENTIA', 'AMYOTROPHIC LATERAL SCLEROSIS, GUAM FORM', 'AMYOTROPHIC LATERAL SCLEROSIS, PARKINSONISM/DEMENTIA COMPLEX OF GUAM', 'AMYOTROPHIC LATERAL SCLEROSIS-PARKINSONISM/DEMENTIA COMPLEX 1', 'AMYOTROPHIC SCLEROSIS', 'BULBAR MOTOR NEURON DISEASE', 'CHARCOT DISEASE', 'DEMENTIA WITH AMYOTROPHIC LATERAL SCLEROSIS', 'DISEASE, LOU-GEHRIGS', 'GEHRIG DISEASE', ""GEHRIG'S DISEASE"", 'GEHRIGS DIS', 'GEHRIGS DISEASE', 'GUAM FORM OF AMYOTROPHIC LATERAL SCLEROSIS', 'LATERAL SCLEROSES, AMYOTROPHIC', 'LOU GEHRIG DIS', 'LOU GEHRIG DISEASE', ""LOU GEHRIG'S DISEASE"", 'LOU GEHRIGS DIS', 'LOU GEHRIGS DISEASE', 'LOU-GEHRIGS DISEASE', 'MOTOR NEURON DIS AMYOTROPHIC LATERAL SCLEROSIS', 'MOTOR NEURON DISEASE, AMYOTROPHIC LATERAL SCLEROSIS', 'MOTOR NEURON DISEASE, BULBAR', 'SCLEROSIS, AMYOTROPHIC LATERAL'], ['ALS1', 'AMYOTROPHIC LATERAL SCLEROSIS 1', 'AMYOTROPHIC LATERAL SCLEROSIS TYPE 1'], MOTOR NEURON DISEASE, ['RILUZOLE', 'RILUZOLE ORAL SOLUBLE FILM (ROSF)'], ['ANTILYMPHOCYTE SERUM', 'ALG', 'ALS', 'ANTILYMPHOCYTE GLOBULIN', 'ANTILYMPHOCYTE SERUMS', 'SERUM, ANTILYMPHOCYTE', 'SERUMS, ANTILYMPHOCYTE'], ['ALS - AMYOTROPHIC LATERAL SCLEROSIS', 'ALS AMYOTROPHIC LATERAL SCLEROSIS', 'AMYOTROPHIC LATERAL SCLEROSIS PARKINSONISM DEMENTIA COMPLEX 1', 'AMYOTROPHIC LATERAL SCLEROSIS WITH DEMENTIA', 'AMYOTROPHIC LATERAL SCLEROSIS, GUAM FORM', 'AMYOTROPHIC LATERAL SCLEROSIS, PARKINSONISM DEMENTIA COMPLEX OF GUAM', 'AMYOTROPHIC LATERAL SCLEROSIS, PARKINSONISM-DEMENTIA COMPLEX OF GUAM', 'AMYOTROPHIC LATERAL SCLEROSIS-PARKINSONISM-DEMENTIA COMPLEX 1', 'CHARCOT DISEASE', 'DEMENTIA WITH AMYOTROPHIC LATERAL SCLEROSIS', 'DISEASE, GUAM', 'DISEASE, LOU-GEHRIGS', 'GEHRIG DISEASE', ""GEHRIG'S DISEASE"", 'GEHRIGS DISEASE', 'GUAM DISEASE', 'GUAM FORM OF AMYOTROPHIC LATERAL SCLEROSIS', 'LOU GEHRIG DISEASE', ""LOU GEHRIG'S DISEASE"", 'LOU-GEHRIGS DISEASE', 'MOTOR NEURON DISEASE, AMYOTROPHIC LATERAL SCLEROSIS', 'SCLEROSIS, AMYOTROPHIC LATERAL', 'AMYOTROPHIC LATERAL SCLEROSIS'], JUVENILE PRIMARY LATERAL SCLEROSIS, ['ACID-LABILE SUBUNIT', 'ACID-LABILE SUBUNIT DEFICIENCY', 'ALS', 'IGFALS', 'IGFBP, SOLUBLE', 'INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN, ACID-LABILE SUBUNIT'], ['JUVENILE PRIMARY LATERAL SCLEROSIS', 'PRIMARY LATERAL SCLEROSIS, JUVENILE', 'PRIMARY LATERAL SCLEROSIS JUVENILE'], MOTOR NEURON DISEASE, ['AT-1501', 'HUMANIZED ANTI-CD40LG IGG1, KAPPA MONOCLONAL ANTIBODY WITH HEAVY CHAIN C220S/C226S/C229S/P238S SUBSTITUTIONS TO ATTENUATE EFFECTOR FUNCTION', 'AT-1501 | TORALIZUMAB'], ['AMYOTROPHIC LATERAL SCLEROSIS TYPE 2', 'ALS2'], ['ALS', 'IGFALS'], MOTOR NEURON DISEASE, ['AMYOTROPHIC LATERAL SCLEROSIS TYPE 6', 'ALS6'], ['CEFTRIAXONE SODIUM', 'ROCEPHIN'], ['ISOLEUCINE', 'BRANCHED CHAIN AMINO ACIDS'], NICOTINAMIDE RIBOSIDE AND PTEROSTILBENE, ['ANTILYMPHOCYTE SERUM', 'ALG', 'ALS', 'ANTILYMPHOCYTE GLOBULIN'], ['CU-ASTM', 'DIACETYL(N(4)-METHYLTHIOSEMICARBAZONATO) COPPER (II)'], ['OZANEZUMAB', 'ANTI-NOGO-A MONOCLONAL ANTIBODY'], ['CANNABIDIOL ', 'CANNABIDIOL AND DELTA-9-TETRAHYDROCANNABINOL'], ['TELBERMIN', 'RECOMBINANT HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR'], [' PTEROSTILBENE', 'NICOTINAMIDE RIBOSIDE AND PTEROSTILBENE'], OXALOACETIC ACID, ['L-THREONINE', 'THREOSTAT'], ['GLATIRAMER ACETATE', 'COPAXONE'], PROTIRELIN INJECTION, ['GM-603', 'OLIGOPEPTIDE CONTAINING 6 AMINO ACIDS (H-PHE-SER-ARG-TYR-ALA-ARG-OH)'], ['GABAPENTIN', 'NEURONTIN'], ['MECASERMIN', 'MYOTROPHIN'], ['DELTA-9-TETRAHYDROCANNABINOL', 'CANNABIDIOL AND DELTA-9-TETRAHYDROCANNABINOL'], ['RILUZOLE', 'RILUTEK'], ['RILUZOLE ORAL SUSPENSION', 'TEGLUTIK'], ['OLESOXIME', '4-CHOLEST-EN-3-ONE, OXIME'], RILUZOLE ORALLY DISOLVING TABLET, ['PMX-205 ACETATE', 'HYDROCINNAMATE-[ORN-PRO-DCHA-TRP-ARG](CH3COO)'], MOTOR NEURON DISEASE, DL-3-N-BUTYLPHTHALIDE, ['CYCLOSPORIN A', 'MITOGARD'], ['ALS', ""LOU GEHRIG'S DISEASE"", 'MOTOR NEURON DISEASE, BULBAR', 'AMYOTROPHIC LATERAL SCLEROSIS'], NOSCAPINE, ['DEXTROMETHORPHAN HYDROBROMIDE', 'DEXTROMETHORPHAN HYDROBROMIDE/QUINIDINE SULFATE', 'NUEDEXTA'], ['AMYOTROPHIC LATERAL SCLEROSIS', 'ALS', 'AMYOTROPHIC LATERAL SCLEROSIS-POLYGLUCOSAN BODIES', 'ARAN-DUCHENNE MUSCULAR ATROPHY', ""GEHRIG'S DISEASE"", ""LOU GEHRIG'S DISEASE"", 'MOTOR SYSTEM DISEASE (FOCAL AND SLOW)'], 4-CHOLEST-EN-3-ONE, OXIME, LEVOSIMENDAN, SARSASAPOGENIN, CILIARY NEUROTROPHIC FACTOR, nan, TALAMPANEL, ['ALS1', 'AMYOTROPHIC LATERAL SCLEROSIS 1', 'AMYOTROPHIC LATERAL SCLEROSIS TYPE 1', 'AMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT', 'AMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT AMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL RECESSIVE, INCLUDED', 'AMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL RECESSIVE', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL', 'AMYOTROPHIC LATERAL SCLEROSIS 1; ALS1', 'AMYOTROPHIC LATERAL SCLEROSIS, AUTOSOMAL DOMINANT', 'AMYOTROPHIC LATERAL SCLEROSIS, FAMILIAL', 'AMYOTROPHIC LATERAL SCLEROSIS, SPORADIC', 'AMYOTROPHIC LATERAL SCLEROSIS, SPORADIC, INCLUDED'], ['LSP-GR3', ""2'-O-METHYL PHOSPHOROTHIOATE 5'-GCUAGGUUUACGGGACCUCU-3'""], ['JUVENILE PRIMARY LATERAL SCLEROSIS', 'JPLS', 'PLS JUVENILE', 'PRIMARY LATERAL SCLEROSIS, JUVENILE'], ARIMOCLOMOL, BIS-CHOLINE TETRATHIOMOLYBDATE, SODIUM CHLORITE, TIRASEMTIV, ['LEUCINE', 'BRANCHED CHAIN AMINO ACIDS'], ['SMILAGENIN', 'COGANE'], ['GLIADIN', 'SUPEROXIDE DISMUTASE, GLIADIN', 'ETR019'], ['VALINE', 'BRANCHED CHAIN AMINO ACIDS'], ['EPI-589', '(R)-2-HYDROXY-2-METHYL-4-(2,4,5-TRIMETHYL-3,6-DIOXOCYCLOHEXA-1,4-DIEN-1-YL) BUTANAMIDE'], ['ALS1', 'AMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT', 'AMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL RECESSIVE', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL', 'AMYOTROPHIC LATERAL SCLEROSIS, SPORADIC', 'FALS', 'AMYOTROPHIC LATERAL SCLEROSIS 1'], AMYOTROPHIC LATERAL SCLEROSIS, ['ACTH', 'REPOSITORY CORTICORTROPIN INJECTION', 'H.P. ACTHAR GEL'], ['QUINIDINE SULFATE', 'DEXTROMETHORPHAN HYDROBROMIDE/QUINIDINE SULFATE', 'NUEDEXTA'], IBUDILAST, ['CREATINE', 'CREAPURE'], [' SODIUM PHENYLBUTYRATE', 'COMBINATION OF SODIUM PHENYLBUTYRATE AND TAUROURSODEOXYCHOLIC ACID DIHYDRATE'], ORGOTEIN FOR INJECTION, FILGRASTIM, LACTOBACILLUS PLANTARUM, ['AMYOTROPHIC LATERAL SCLEROSIS', 'ALS', 'ALS - AMYOTROPHIC LATERAL SCLEROSIS', 'ALS AMYOTROPHIC LATERAL SCLEROSIS', 'AMYTROPHIC LATERAL SCLEROSIS', 'BULBAR MOTOR NEURON DISEASE', 'CHARCOT DISEASE', 'DISEASE, LOU-GEHRIGS', 'GEHRIG DISEASE', ""GEHRIG'S DISEASE"", 'GEHRIGS DISEASE', 'LOU GEHRIG DISEASE', ""LOU GEHRIG'S DISEASE"", 'LOU-GEHRIGS DISEASE', 'MOTOR NEURON DISEASE, AMYOTROPHIC LATERAL SCLEROSIS', 'SCLEROSIS, AMYOTROPHIC LATERAL'], EDARAVONE, EDARAVONE, DEXPRAMIPEXOLE, ['L-2-OXOTHIAZOLIDINE-4-CARBOXYLIC ACID', 'PROCYSTEINE'], MASITINIB MESYLATE, ['AEOL-10150', '[5,10,15,20-TETRAKIS(1,3-DIETHYLIMIDAZOLIUM-2-YL)PORPHYRINATO] MANGANESE(III)PENTACHLORIDE'], ['HER-902 ', 'RECOMBINANT HUMAN CEREBRAL DOPAMINE NEUROTROPHIC FACTOR'], [' TAUROURSODEOXYCHOLIC ACID DIHYDRATE', 'COMBINATION OF SODIUM PHENYLBUTYRATE AND TAUROURSODEOXYCHOLIC ACID DIHYDRATE'], ['NI-204', 'RECOMBINANT HUMAN ANTIBODY DIRECTED AGAINST HUMAN MISFOLDED SUPEROXIDE DISMUTASE 1'], CILIARY NEUROTROPHIC FACTOR, RECOMBINANT HUMAN, NEUROTROPHIN-1, RECOMBINANT METHIONYL BRAIN-DERIVED NEUROTROPHIC FACTOR, PHOSPHOROTHIOATE OLIGONUCLEOTIDE, ['AUTOLOGOUS OLFACTORY NEURAL PROGENITORS', 'RHINOCYTES'], ['EPI-589', '(R)-2-HYDROXY-2-METHYL-4-(2,4,5-TRIMETHYL-3,6-DIOXOCYCLOHEXA-1,4-DIEN-1-YL) BUTANAMIDE'], CAPRINE HYPERIMMUNE SERUM AGAINST HIV LYSATE, NDX-PEPTIDES, EX-VIVO EXPANDED AUTOLOGOUS BONE MARROW-DERIVED MESENCHYMAL STEM CELLS, ['ALS', 'CHARCOT DISEASE', 'LOU GEHRIG DISEASE', ""LOU GEHRIG'S DISEASE"", 'MOTOR NEURON DISEASE, BULBAR', 'AMYOTROPHIC LATERAL SCLEROSIS'], HUMAN SPINAL CORD DERIVED NEURAL STEM CELLS, ['AEOL-10150', '[5,10,15,20-TETRAKIS(1,3-DIETHYLIMIDAZOLIUM-2-YL)PORPHYRINATO] MANGANESE(III)PENTACHLORIDE'], ['MESENCHYMAL STROMAL CELLS SECRETING NEUROTROPHIC FACTORS', 'NUROWN'], HEAT SHOCK PROTEIN 70, HUMAN UMBILICAL TISSUE DERIVED CELLS (HUTC), ['ALS', 'ALS (AMYOTROPHIC LATERAL SCLEROSIS)', 'AMYOTROPHIC LATERAL SCLEROSIS', 'AMYOTROPHIC LATERAL SCLEROSIS (DISORDER)', 'AMYOTROPHIC LATERAL SCLEROSIS, GUAM FORM', 'AMYOTROPHIC SCLEROSIS', 'DEMENTIA WITH AMYOTROPHIC LATERAL SCLEROSIS', 'DISEASE, LOU-GEHRIGS', 'GEHRIG DISEASE', 'GEHRIGS DIS', 'GEHRIGS DISEASE', 'GUAM FORM OF AMYOTROPHIC LATERAL SCLEROSIS', 'LATERAL SCLEROSES, AMYOTROPHIC', 'LOU GEHRIG DIS', 'LOU GEHRIG DISEASE', ""LOU GEHRIG'S DISEASE"", 'LOU GEHRIGS DIS', 'MOTOR NEURON DIS AMYOTROPHIC LATERAL SCLEROSIS', 'MOTOR NEURON DISEASE, AMYOTROPHIC LATERAL SCLEROSIS', 'MOTOR NEURON DISEASE, BULBAR'], ['HUMAN GLIAL RESTRICTED PROGENITOR CELLS AND THEIR PROGENY', 'Q-CELLS'], ['SOD1 WT ALLELE', 'ALS', 'ALS1', 'IPOA', 'SOD', 'SUPEROXIDE DISMUTASE 1, SOLUBLE (AMYOTROPHIC LATERAL SCLEROSIS 1 (ADULT)) WT ALLELE'], ['ALLOGENEIC MOTOR NEURON PROGENITOR CELLS DERIVED FROM HUMAN EMBRYONIC STEM CELLS', 'MOTORGRAFT (TM)'], DNA PLASMID VECTOR (PCK-HGFX7) EXPRESSING HUMAN HEPATOCYTE GROWTH FACTOR, ['JUVENILE PRIMARY LATERAL SCLEROSIS', 'JPLS', 'JUVENILE PLS', 'PLS JUVENILE', 'PLS, JUVENILE', 'PLSJ', 'PRIMARY LATERAL SCLEROSIS JUVENILE', 'PRIMARY LATERAL SCLEROSIS, JUVENILE'], AUTOLOGOUS ADIPOSE DERIVED MESENCHYMAL STROMAL CELLS, ['MONONUCLEAR ENRICHED FRACTION OF HUMAN UMBILICAL CORD BLOOD', 'U-CORD-CELL(R)'], ANTISENSE OLIGONUCLEOTIDE INHIBITOR OF THE EXPRESSION OF SUPEROXIDE DISMUTASE 1 GENE, ['AMYOTROPHIC LATERAL SCLEROSIS TYPE 11', 'ALS11', 'AMYOTROPHIC LATERAL SCLEROSIS 11'], ELECTROKINETICALLY ALTERED SALINE SOLUTION WITH AN ELEVATED DISSOLVED OXYGEN CONCENTRATION, ['AMYOTROPHIC LATERAL SCLEROSIS TYPE 10', 'ALS10', 'AMYOTROPHIC LATERAL SCLEROSIS 10'], HUMANIZED ANTI-CD40LG IGG1, KAPPA MONOCLONAL ANTIBODY WITH HEAVY CHAIN C220S/C226S/C229S/P238S SUBSTITUTIONS TO ATTENUATE EFFECTOR FUNCTION, LENZUMESTROCEL, ['AMYOTROPHIC LATERAL SCLEROSIS TYPE 9', 'ALS9', 'AMYOTROPHIC LATERAL SCLEROSIS 9'], ['MOTOR NEURON DISEASE', 'ANTERIOR HORN CELL DISEASE', 'DEGENERATIVE MOTOR SYSTEM DISEASE', 'DISEASE OF MOTOR NEURON', 'DISEASE OR DISORDER OF MOTOR NEURON', 'DISORDER OF MOTOR NEURON', 'MND - MOTOR NEURONE DISEASE', 'MOTOR NEURON DISEASE OR DISORDER', 'MOTOR NEURON DISEASES', 'MOTOR NEURONE DISEASE', 'MOTOR SYSTEM DISEASE', 'MOTOR SYSTEM DISEASES', 'NEURON DISEASE, MOTOR', 'NEURON DISEASES, MOTOR'], S-[+]-APOMORPHINE, ['CLENBUTEROL', 'SPIROPENT'], ['AMYOTROPHIC LATERAL SCLEROSIS TYPE 8', 'ALS8', 'AMYOTROPHIC LATERAL SCLEROSIS 8'], ['AMYOTROPHIC LATERAL SCLEROSIS TYPE 1', 'ALS1', 'AMYOTROPHIC LATERAL SCLEROSIS 1', 'AMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL DOMINANT', 'AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL', 'AMYOTROPHIC LATERAL SCLEROSIS, AUTOSOMAL DOMINANT', 'FALS', 'SOD1-RELATED AMYOTROPHIC LATERAL SCLEROSIS'], AMYOTROPHIC LATERAL SCLEROSIS, SPORADIC, ['AMYOTROPHIC LATERAL SCLEROSIS TYPE 4', 'ALS4', 'AMYOTROPHIC LATERAL SCLEROSIS 4'], ['AMYOTROPHIC LATERAL SCLEROSIS TYPE 5', 'ALS5', 'AMYOTROPHIC LATERAL SCLEROSIS 5'], ['AMYOTROPHIC LATERAL SCLEROSIS', 'ALS', 'LOU GEHRIG DISEASE'], AMYOTROPHIC LATERAL SCLEROSIS 1, AMYOTROPHIC LATERAL SCLEROSIS, PRIMARY LATERAL SCLEROSIS, JUVENILE, ['JPLS', 'JUVENILE PLS', 'PLS JUVENILE', 'PLS, JUVENILE', 'PRIMARY LATERAL SCLEROSIS, JUVENILE', 'PRIMARY LATERAL SCLEROSIS, JUVENILE; PLSJ', 'JUVENILE PRIMARY LATERAL SCLEROSIS'], ['JPLS', 'JUVENILE PLS', 'JUVENILE PRIMARY LATERAL SCLEROSIS', 'PLS JUVENILE', 'PLS, JUVENILE', 'PRIMARY LATERAL SCLEROSIS, JUVENILE', 'PRIMARY LATERAL SCLEROSIS, JUVENILE; PLSJ']"
116319,27,"SACCADIC PURSUIT MOVEMENTS, SACCADIC PURSUIT MOVEMENTS|SACCADIC SLOW PURSUIT|SACCADIC SMOOTH PURSUIT, SACCADIC SMOOTH PURSUIT, SACCADIC SMOOTH PURSUIT|SACCADIC PURSUIT MOVEMENTS|SACCADIC SLOW PURSUIT","SACCADIC PURSUIT MOVEMENTS, ['SACCADIC PURSUIT MOVEMENTS', 'SACCADIC SLOW PURSUIT', 'SACCADIC SMOOTH PURSUIT'], SACCADIC SMOOTH PURSUIT, ['SACCADIC SMOOTH PURSUIT', 'SACCADIC PURSUIT MOVEMENTS', 'SACCADIC SLOW PURSUIT']"
131867,27,"PALLOR|PALE|PALENESS, PALENESS|SKIN PALENESS|PALLOR, CLAMMY SKIN|PALLOR, PALENESS, PALLOR, PALLORS|PALLOR, PALLOR|PALE|PALE - SYMPTOM|PALE COMPLEXION|PALENESS|PALLORS|POSTTRANSPLANT ACUTE LIMBIC ENCEPHALITIS|SKIN PALENESS","['PALLOR', 'PALE', 'PALENESS'], ['PALENESS', 'SKIN PALENESS', 'PALLOR'], ['CLAMMY SKIN', 'PALLOR'], PALENESS, PALLOR, ['PALLORS', 'PALLOR'], ['PALLOR', 'PALE', 'PALE - SYMPTOM', 'PALE COMPLEXION', 'PALENESS', 'PALLORS', 'POSTTRANSPLANT ACUTE LIMBIC ENCEPHALITIS', 'SKIN PALENESS']"
160866,27,MUSCLE WEAKNESS|MUSCULAR WEAKNESS,"['MUSCLE WEAKNESS', 'MUSCULAR WEAKNESS']"
62679,27,"SPASTICITY OF FACIAL MUSCLES|INCREASED STIFFNESS OF FACIAL MUSCLES|INCREASED TONE OF FACIAL MUSCLES|SPASTICITY OF THE FACIAL MUSCLES, SPASTICITY OF THE FACIAL MUSCLES|INCREASED STIFFNESS OF FACIAL MUSCLES|INCREASED TONE OF FACIAL MUSCLES|SPASTICITY OF FACIAL MUSCLES, SPASTICITY OF FACIAL MUSCLES, SPASTICITY OF THE FACIAL MUSCLES","['SPASTICITY OF FACIAL MUSCLES', 'INCREASED STIFFNESS OF FACIAL MUSCLES', 'INCREASED TONE OF FACIAL MUSCLES', 'SPASTICITY OF THE FACIAL MUSCLES'], ['SPASTICITY OF THE FACIAL MUSCLES', 'INCREASED STIFFNESS OF FACIAL MUSCLES', 'INCREASED TONE OF FACIAL MUSCLES', 'SPASTICITY OF FACIAL MUSCLES'], SPASTICITY OF FACIAL MUSCLES, SPASTICITY OF THE FACIAL MUSCLES"
98084,27,"SPASTIC QUADRIPARESIS, SPASTIC QUADRIPARESIS|SPASTIC TETRAPARESIS, SPASTIC TETRAPARESIS, SPASTIC TETRAPARESIS|SPASTIC QUADRIPARESIS","SPASTIC QUADRIPARESIS, ['SPASTIC QUADRIPARESIS', 'SPASTIC TETRAPARESIS'], SPASTIC TETRAPARESIS, ['SPASTIC TETRAPARESIS', 'SPASTIC QUADRIPARESIS']"
122299,27,"SPASTICITY OF PHARYNGEAL MUSCLES, SPASTICITY OF PHARYNGEAL MUSCLES, SPASTICITY OF PHARYNGEAL MUSCLES","SPASTICITY OF PHARYNGEAL MUSCLES, SPASTICITY OF PHARYNGEAL MUSCLES, SPASTICITY OF PHARYNGEAL MUSCLES"
855067,27,"ONSET IN EARLY CHILDHOOD, ONSET EARLY CHILDHOOD, EARLY CHILDHOOD ONSET, DISEASE USUALLY BECOMES APPARENT IN EARLY CHILDHOOD, ONSET EARLY CHILDHOOD|DISEASE USUALLY BECOMES APPARENT IN EARLY CHILDHOOD|EARLY CHILDHOOD ONSET|ONSET IN EARLY CHILDHOOD","ONSET IN EARLY CHILDHOOD, ONSET EARLY CHILDHOOD, EARLY CHILDHOOD ONSET, DISEASE USUALLY BECOMES APPARENT IN EARLY CHILDHOOD, ['ONSET EARLY CHILDHOOD', 'DISEASE USUALLY BECOMES APPARENT IN EARLY CHILDHOOD', 'EARLY CHILDHOOD ONSET', 'ONSET IN EARLY CHILDHOOD']"
818748,27,"SPASTICITY OF LOWER AND UPPER LIMBS|SPASTICITY OF UPPER AND LOWER LIMBS|SPASTICITY, UPPER AND LOWER LIMBS, SPASTICITY OF LOWER AND UPPER LIMBS, SPASTICITY, UPPER AND LOWER LIMBS, SPASTICITY OF UPPER AND LOWER LIMBS","['SPASTICITY OF LOWER AND UPPER LIMBS', 'SPASTICITY OF UPPER AND LOWER LIMBS', 'SPASTICITY, UPPER AND LOWER LIMBS'], SPASTICITY OF LOWER AND UPPER LIMBS, SPASTICITY, UPPER AND LOWER LIMBS, SPASTICITY OF UPPER AND LOWER LIMBS"
5366496,27,,
195603,27,"DIFFICULTY IN TONGUE MOVEMENTS, DIFFICULTY IN LINGUAL MOVEMENTS|DIFFICULTY IN TONGUE MOVEMENTS|HYPOKINESIA OF THE TONGUE|LINGUAL HYPOKINESIA, DIFFICULTY IN TONGUE MOVEMENTS|DIFFICULTY IN LINGUAL MOVEMENTS|HYPOKINESIA OF THE TONGUE|LINGUAL HYPOKINESIA","DIFFICULTY IN TONGUE MOVEMENTS, ['DIFFICULTY IN LINGUAL MOVEMENTS', 'DIFFICULTY IN TONGUE MOVEMENTS', 'HYPOKINESIA OF THE TONGUE', 'LINGUAL HYPOKINESIA'], ['DIFFICULTY IN TONGUE MOVEMENTS', 'DIFFICULTY IN LINGUAL MOVEMENTS', 'HYPOKINESIA OF THE TONGUE', 'LINGUAL HYPOKINESIA']"
5366498,27,,
5366500,27,,
5366502,27,,
5366504,27,,
5366506,27,,
5366512,27,,
5366508,27,,
5366510,27,,
130260,27,"AMYOTROPHY|AMYOTROPHY INVOLVING THE EXTREMITIES|MUSCLE ATROPHY|MUSCLE ATROPHY, NEUROGENIC|MUSCLE DEGENERATION|MUSCLE HYPOTROPHY|MUSCLE WASTING|MUSCULAR ATROPHY|NEUROGENIC MUSCLE ATROPHY|NEUROGENIC MUSCLE ATROPHY, ESPECIALLY IN THE LOWER LIMBS|NEUROGENIC MUSCULAR ATROPHY|SKELETAL MUSCLE ATROPHY","['AMYOTROPHY', 'AMYOTROPHY INVOLVING THE EXTREMITIES', 'MUSCLE ATROPHY', 'MUSCLE ATROPHY, NEUROGENIC', 'MUSCLE DEGENERATION', 'MUSCLE HYPOTROPHY', 'MUSCLE WASTING', 'MUSCULAR ATROPHY', 'NEUROGENIC MUSCLE ATROPHY', 'NEUROGENIC MUSCLE ATROPHY, ESPECIALLY IN THE LOWER LIMBS', 'NEUROGENIC MUSCULAR ATROPHY', 'SKELETAL MUSCLE ATROPHY']"
5366514,27,,
5366516,27,,
5366518,27,,
187969,27,"PSEUDOBULBAR BEHAVIORAL SYMPTOMS|PSEUDOBULBAR BEHAVIOURAL SYMPTOMS, PSEUDOBULBAR BEHAVIORAL SYMPTOMS","['PSEUDOBULBAR BEHAVIORAL SYMPTOMS', 'PSEUDOBULBAR BEHAVIOURAL SYMPTOMS'], PSEUDOBULBAR BEHAVIORAL SYMPTOMS"
5366520,27,,
5366524,27,,
5366526,27,,
5366528,27,,
5366530,27,,
5366532,27,,
5366534,27,,
5366536,27,,
5387123,27,,
192009,27,"ABNORMAL UPPER MOTOR NEURON MORPHOLOGY|ABNORMAL SHAPE OF UPPER MOTOR NEURON, ABNORMAL SHAPE OF UPPER MOTOR NEURON|ABNORMAL UPPER MOTOR NEURON MORPHOLOGY","['ABNORMAL UPPER MOTOR NEURON MORPHOLOGY', 'ABNORMAL SHAPE OF UPPER MOTOR NEURON'], ['ABNORMAL SHAPE OF UPPER MOTOR NEURON', 'ABNORMAL UPPER MOTOR NEURON MORPHOLOGY']"
5366538,27,,
5366540,27,,
5366542,27,,
5366544,27,,
5366550,27,,
5366546,27,,
5366548,27,,
5378089,27,,
5366552,27,,
5366554,27,,
5390053,27,,
5389549,27,,
5373771,27,,
5373773,27,,
5378087,27,,
5390885,27,,
847972,27,"UPPER MOTOR NEURON SIGNS, UPPER MOTOR NEURON SIGNS","UPPER MOTOR NEURON SIGNS, UPPER MOTOR NEURON SIGNS"
848837,27,"PSEUDOBULBAR SYMPTOMS (UNCONTROLLED LAUGHTER, WEEPING), PSEUDOBULBAR SYMPTOMS (UNCONTROLLED LAUGHTER, WEEPING)","PSEUDOBULBAR SYMPTOMS (UNCONTROLLED LAUGHTER, WEEPING), PSEUDOBULBAR SYMPTOMS (UNCONTROLLED LAUGHTER, WEEPING)"
848713,27,"NO SENSORY ABNORMALITIES, NO SENSORY ABNORMALITIES","NO SENSORY ABNORMALITIES, NO SENSORY ABNORMALITIES"
818920,27,"ALLELIC DISORDER TO INFANTILE-ONSET ASCENDING SPASTIC PARALYSIS (IAHSP, 607225), ALLELIC DISORDER TO INFANTILE-ONSET ASCENDING SPASTIC PARALYSIS (IAHSP, 607225)","ALLELIC DISORDER TO INFANTILE-ONSET ASCENDING SPASTIC PARALYSIS (IAHSP, 607225), ALLELIC DISORDER TO INFANTILE-ONSET ASCENDING SPASTIC PARALYSIS (IAHSP, 607225)"
5352600,27,,
166446,27,MOTOR NEURON DEGENERATION|MOTOR NEURON ATROPHY,"['MOTOR NEURON DEGENERATION', 'MOTOR NEURON ATROPHY']"
5352602,27,,
848864,27,"CORTICAL ATROPHY WITH LOSS OF PYRAMIDAL NEURONS IN THE MOTOR CORTEX, CORTICAL ATROPHY WITH LOSS OF PYRAMIDAL NEURONS IN THE MOTOR CORTEX","CORTICAL ATROPHY WITH LOSS OF PYRAMIDAL NEURONS IN THE MOTOR CORTEX, CORTICAL ATROPHY WITH LOSS OF PYRAMIDAL NEURONS IN THE MOTOR CORTEX"
848765,27,"LATERAL CORTICOSPINAL TRACTS SHOW ATROPHY, PALLOR, AND DEGENERATION, LATERAL CORTICOSPINAL TRACTS SHOW ATROPHY, PALLOR, AND DEGENERATION","LATERAL CORTICOSPINAL TRACTS SHOW ATROPHY, PALLOR, AND DEGENERATION, LATERAL CORTICOSPINAL TRACTS SHOW ATROPHY, PALLOR, AND DEGENERATION"
848807,27,"ABSENCE OF LOWER MOTOR NEURON INVOLVEMENT, ABSENCE OF LOWER MOTOR NEURON INVOLVEMENT","ABSENCE OF LOWER MOTOR NEURON INVOLVEMENT, ABSENCE OF LOWER MOTOR NEURON INVOLVEMENT"
827523,27,"CAUSED BY MUTATION IN THE ALSIN GENE (ALS2, 606352.0002), CAUSED BY MUTATION IN THE ALSIN GENE (ALS2, 606352.0002)","CAUSED BY MUTATION IN THE ALSIN GENE (ALS2, 606352.0002), CAUSED BY MUTATION IN THE ALSIN GENE (ALS2, 606352.0002)"
827511,27,"ALLELIC DISORDER TO JUVENILE AMYOTROPHIC LATERAL SCLEROSIS 2 (ALS2, 205100), ALLELIC DISORDER TO JUVENILE AMYOTROPHIC LATERAL SCLEROSIS 2 (ALS2, 205100)","ALLELIC DISORDER TO JUVENILE AMYOTROPHIC LATERAL SCLEROSIS 2 (ALS2, 205100), ALLELIC DISORDER TO JUVENILE AMYOTROPHIC LATERAL SCLEROSIS 2 (ALS2, 205100)"
5352604,27,,
16351,27,AMYOTROPHIC LATERAL SCLEROSIS TYPE 3|ALS3|AMYOTROPHIC LATERAL SCLEROSIS 3,"['AMYOTROPHIC LATERAL SCLEROSIS TYPE 3', 'ALS3', 'AMYOTROPHIC LATERAL SCLEROSIS 3']"
5352606,27,,
5365564,27,,
5365566,27,,
5352608,27,,
5350954,27,,
5365568,27,,
78508,27,ANTERIOR HORN CELL LOSS|DEGENERATION OF ALPHA-MOTOR NEURONS IN ANTERIOR HORN CELLS OF THE SPINAL CORD|DEGENERATION OF SPINAL CORD ANTERIOR HORN CELLS|LOSS OF SPINAL CORD ANTERIOR HORN CELLS|PROGRESSIVE LOSS OF ANTERIOR HORN CELLS|SPINAL CORD ANTERIOR HORN CELL DEGENERATION|DEGENERATION OF ANTERIOR HORN CELLS,"['ANTERIOR HORN CELL LOSS', 'DEGENERATION OF ALPHA-MOTOR NEURONS IN ANTERIOR HORN CELLS OF THE SPINAL CORD', 'DEGENERATION OF SPINAL CORD ANTERIOR HORN CELLS', 'LOSS OF SPINAL CORD ANTERIOR HORN CELLS', 'PROGRESSIVE LOSS OF ANTERIOR HORN CELLS', 'SPINAL CORD ANTERIOR HORN CELL DEGENERATION', 'DEGENERATION OF ANTERIOR HORN CELLS']"
5350956,27,,
5365570,27,,
5352610,27,,
129478,27,PAUSES IN BREATHING WHILE SLEEPING|SLEEP APNOEA|SLEEP APNEA,"['PAUSES IN BREATHING WHILE SLEEPING', 'SLEEP APNOEA', 'SLEEP APNEA']"
5350958,27,,
5365572,27,,
5350960,27,,
5365574,27,,
5352612,27,,
5350962,27,,
5365576,27,,
5365258,27,,
5350964,27,,
5365578,27,,
5352614,27,,
5365260,27,,
5350966,27,,
5365582,27,,
5388279,27,,
16348,27,AMYOTROPHIC LATERAL SCLEROSIS TYPE 7|ALS7|AMYOTROPHIC LATERAL SCLEROSIS 7,"['AMYOTROPHIC LATERAL SCLEROSIS TYPE 7', 'ALS7', 'AMYOTROPHIC LATERAL SCLEROSIS 7']"
5353280,27,,
5353508,27,,
5365262,27,,
5353112,27,,
5366900,27,,
5352616,27,,
5353282,27,,
5373313,27,,
5353802,27,,
5376953,27,,
5353114,27,,
5366902,27,,
5353284,27,,
5358870,27,,
5367084,27,,
5373315,27,,
5370936,27,,
5388637,27,,
5369662,27,,
5368784,27,,
5354756,27,,
154583,27,MUSCLE CRAMPS|MUSCLE SPASM,"['MUSCLE CRAMPS', 'MUSCLE SPASM']"
5353286,27,,
5367552,27,,
2595574,27,,
5340002,27,,
5367086,27,,
5373323,27,,
5358212,27,,
5357928,27,,
5356086,27,,
5356162,27,,
5343842,27,,
5354604,27,,
5367088,27,,
5373263,27,,
5373325,27,,
5358214,27,,
5367090,27,,
5343844,27,,
5356088,27,,
5356164,27,,
5375057,27,,
5364954,27,,
83060,27,DEGENERATION OF LATERAL CORTICOSPINAL TRACTS|DEGENERATION OF THE LATERAL CORTICOSPINAL TRACTS,"['DEGENERATION OF LATERAL CORTICOSPINAL TRACTS', 'DEGENERATION OF THE LATERAL CORTICOSPINAL TRACTS']"
5358216,27,,
5358220,27,,
5348738,27,,
5358222,27,,
5357104,27,,
205036,27,TROUBLE BREATHING|DYSPNEA,"['TROUBLE BREATHING', 'DYSPNEA']"
5357106,27,,
5357108,27,,
17957,27,"JUVENILE AMYOTROPHIC LATERAL SCLEROSIS|AMYOTROPHIC LATERAL SCLEROSIS, JUVENILE|JALS|JUVENILE CHARCOT DISEASE|JUVENILE LOU GEHRIG DISEASE","['JUVENILE AMYOTROPHIC LATERAL SCLEROSIS', 'AMYOTROPHIC LATERAL SCLEROSIS, JUVENILE', 'JALS', 'JUVENILE CHARCOT DISEASE', 'JUVENILE LOU GEHRIG DISEASE']"
136319,27,PAIN,['PAIN']
182459,27,DECREASED SALIVARY FLOW|DRY MOUTH|DRY MOUTH SYNDROME|REDUCED SALIVATION|XEROSTOMIA,"['DECREASED SALIVARY FLOW', 'DRY MOUTH', 'DRY MOUTH SYNDROME', 'REDUCED SALIVATION', 'XEROSTOMIA']"
95385,27,AGITATION,AGITATION
143736,27,RESPIRATORY FAILURE,['RESPIRATORY FAILURE']
128647,27,FATIGABLE WEAKNESS OF RESPIRATORY MUSCLES,FATIGABLE WEAKNESS OF RESPIRATORY MUSCLES
128455,27,FATIGABLE WEAKNESS OF BULBAR MUSCLES,FATIGABLE WEAKNESS OF BULBAR MUSCLES
150878,27,"GENERALIZED WEAKNESS|MUSCLE WEAKNESS, DIFFUSE|MUSCLE WEAKNESS, GENERALIZED|GENERALIZED MUSCLE WEAKNESS","['GENERALIZED WEAKNESS', 'MUSCLE WEAKNESS, DIFFUSE', 'MUSCLE WEAKNESS, GENERALIZED', 'GENERALIZED MUSCLE WEAKNESS']"
128667,27,FATIGABLE WEAKNESS OF SWALLOWING MUSCLES,FATIGABLE WEAKNESS OF SWALLOWING MUSCLES
160420,27,ABNORMAL RESPIRATION|FUNCTIONAL RESPIRATORY ABNORMALITY|RESPIRATORY PROBLEM,"['ABNORMAL RESPIRATION', 'FUNCTIONAL RESPIRATORY ABNORMALITY', 'RESPIRATORY PROBLEM']"
87456,27,LARYNGOSPASM,LARYNGOSPASM
139525,27,ABNORMALITY OF THE BLADDER,ABNORMALITY OF THE BLADDER